Current state of institutional sales?

Very interested in trying to move into this space from my current role (internal wholesaler at a large AM firm). I’ve heard the space is dying out but regardless I’d still want to make the jump as it is more market based than my current role. Curious to hear people’s thoughts/advice on it’s current state.

 

Based on the most helpful WSO content, institutional sales offers a blend of great pay, fewer hours than in corporate finance or research, less stress than in trading, and a nice blend of travel and office work. The hours typically follow the market, with a few tacked on at the end of the day after the market closes.

In the context of an IPO, salespeople play a crucial role. They start their involvement a week or two prior to the roadshow, brushing up on the offering company, making calls to their accounts, and pitching the deal. They set up meetings between the portfolio manager and the management team of the company issuing the offering. During the roadshow, salespeople from the lead underwriter often attend the meeting between the company and the buy-side PM.

In terms of compensation, IPOs typically cost the company going public 7 percent of the gross proceeds raised in the offering. That 7 percent is divided between sales, syndicate and investment banking (i.e. corporate finance) in approximately the following manner: 60 percent to Sales, 20 percent to corporate finance, 20 percent to Syndicate.

However, it's important to note that some institutional salespeople complain that many buy-siders disregard their calls, that compensation can exhibit volatile mood swings, and that they feel overeducated for what they do.

So, while there may be challenges, institutional sales can offer a rewarding career for those who are well-suited to it.

Sources: Institutional Sales Analyst Job Description and Overview, State of Market Discussion

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Depends highly on the market and the products you'll be part of.

During my time on the buyside in DCM, I witnessed alot of day-to-day responsibilities of institutional sales being replaced by new functions on Bloomberg or by more streamlined backends. Before I left, most sales people were there to take new issues orders (which Bloomberg has been working on automating), pitching trade ideas which suits their traders book/finding liquidity for another client, general relationship management, and the occasional trade which was too sensitive/large to be done electronically. End result of this is less need for more bodies on trade floors in a position with limited upward mobility and many people staying there for life (or until the bank lets them go). 

I can't see institutional sales going away as clients will always need a human point of contact especially for OTC markets or more complex products/derivatives, but I can see more of their tasks being automated and it would be up to the sales person to add value instead of just expecting activity to come their way. For example, I had many sales coverages at various banks just ping me over BBG asking if I would be trading at all today or just copy and paste runs their trader had already sent vs ones that would actively pitch ideas, analyze my book and suggest trades, keep my team appraised of new deals or syndication activity coming down the pipe, booking dinners/presentations/events with my team and various parties at their bank, etc.  

 
Most Helpful

Reprehenderit tempore ut et. Et voluptate eaque voluptatibus eius quia. Voluptas pariatur corrupti eos ipsa ex.

Est nihil ut et aut quos. Enim natus ipsa autem sequi. Exercitationem blanditiis iusto dolores dicta necessitatibus non vitae. Ullam voluptas at blanditiis perferendis aut et. Explicabo in voluptas non dolore. Et quo ut neque et vitae.

Illo perspiciatis sed distinctio iure eveniet. Doloremque suscipit quia eius voluptates omnis dignissimos eum porro. Harum repellat nostrum voluptatem illo. Et eum explicabo in consequuntur excepturi est ut.

Iure aut quibusdam deserunt suscipit. Sed ad soluta perferendis delectus quia. Est velit consequuntur nihil eaque ut. Tenetur officia nemo et facilis. Similique nam cumque voluptatem cupiditate ut tempore qui. Omnis maiores laudantium dolorem officia aut reiciendis cupiditate.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”